drugset / Trial / NCT00160238

Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy

NCT00160238

Phase 4 Completed 20 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to compare the effects of Betaserc 24mg and placebo on compensation of postural and locomotor deficits (static and dynamic posturography) after vestibular neurotomy in patients suffering from disabling Menière's disease.

Timeline

Start
2003-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Betahistine Small molecule 24 mg

Indications